GHSI — Guardion Health Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- $4.22m
- -$10.60m
- $12.25m
- 36
- 70
- 56
- 54
Annual cashflow statement for Guardion Health Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.9 | -8.57 | -24.7 | -14.9 | 0.158 |
| Depreciation | |||||
| Non-Cash Items | 4.8 | 0.791 | 13.8 | 8.12 | -3.97 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.432 | -0.299 | -0.437 | -1.89 | -0.573 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -6.03 | -8.01 | -10.6 | -7.45 | -4.37 |
| Capital Expenditures | -0.171 | -0.041 | -0.075 | -0.006 | -0.004 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.006 | -30.9 | 5 | 0.02 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.171 | -0.035 | -31 | 4.99 | 0.016 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.6 | 5.45 | 37.2 | 14.3 | -5.19 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.4 | -2.6 | -4.42 | 11.8 | -9.55 |